Crossmark

Functional improvements in patients with lymphangioleiomyomatosis after sirolimus: an observational study

Crossref DOI link: https://doi.org/10.1186/s13023-018-0775-9

Published Online: 2018-02-20

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Zhan, Yongzhong

Shen, Lisha

Xu, Wenshuai

Wu, Xiuxiu

Zhang, Weihong

Wang, Jun

Li, Xue

Yang, Yanli

Tian, Xinlun

Xu, Kai-Feng http://orcid.org/0000-0002-7662-531X
Funding

Funding for this research was provided by:

National Key Research and Development Program of China (2016YFC0901502)

Beijing Municipal Science and Technology Project (Z151100003915126)

National Natural Science Foundation of China (81570061)
More Information

Article History

Received: 7 November 2017

Accepted: 12 February 2018

First Online: 20 February 2018

Ethics approval and consent to participate

: The study was part of the LAM registry study of PUMCH. The protocol was approved by the Ethical Committee of Peking Union Medical College Hospital (S-379). All subjects included in this study signed informed consent documents.

: Consent for publication was obtained from all participants.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.